Status:
SUSPENDED
Cognitive Rehabilitation for Opioid Abuse-related Cognitive Impairment
Lead Sponsor:
Oklahoma State University Center for Health Sciences
Conditions:
Substance-Related Disorders
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Research has consistently found that cognitive impairment is common in persons with a history of substance abuse. The most commonly identified impairments across all substances are in attentional and ...
Eligibility Criteria
Inclusion
- Has completed the detoxification process
- Has completed at least 8 years of formal education
- Speaks and reads English fluently
- Is beginning residential inpatient treatment for opioid abuse (note: may be receiving treatment for polysubstance abuse but opioid must be one of their regular drugs of abuse)
Exclusion
- Unable to self-consent (has a proxy for medical decision-making, legal guardian, or been otherwise determined unable to give consent)
- Past diagnosis or suspected current diagnosis of a neurodevelopmental disorder (e.g., autism, learning disability), attention-deficit disorder, or neurocognitive disorder (e.g., dementia)
- History of major head trauma (defined as loss of consciousness for 30 minutes or longer) or brain surgery. (Note: History of concussion, including brief loss of consciousness, is okay)
Key Trial Info
Start Date :
March 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04404348
Start Date
March 6 2020
End Date
December 1 2020
Last Update
September 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
12&12, Inc
Tulsa, Oklahoma, United States, 74135